During translation, multiple ribosomes travel along the nucleic acid chain to build polypeptides that become functional proteins. Occasionally, these molecular decoders pause on the mRNA, either ...

In the fast-evolving field of medical science, a new artificial intelligence model may be about to change the way mRNA-based drugs and vaccines are designed. Developed through a collaboration between ...

Sanofi has agreed to buy US biotech company Translate Bio in a $3.2 billion (€2.69bn) deal, as it bets on next-generation mRNA vaccine technology beyond the Covid-19 pandemic. Sanofi said it would ...

Amid its ongoing efforts to invest in mRNA technology, Sanofi said Aug. 3 it will acquire clinical-stage mRNA therapeutics company Translate Bio. The French drugmaker will acquire all outstanding ...

-- MRT5500 developed under a collaboration agreement with Sanofi Pasteur; Phase 1/2 clinical trial underway with clinical data anticipated in the third quarter of 2021 -- LEXINGTON, Mass., April 19, ...